Eiropas Savienība - vācu - EMA (European Medicines Agency)

gilead sciences ireland uc - sofosbuvir - hepatitis c, chronisch - antivirale mittel zur systemischen anwendung - sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adult and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 und 5. für hepatitis-c-virus (hcv) genotyp spezifische aktivität, siehe abschnitte 4. 4 und 5. sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adults and paediatric patients aged 3 years and above (see sections 4. 2, 4. 4 und 5. für hepatitis-c-virus (hcv) genotyp spezifische aktivität, siehe abschnitte 4. 4 und 5.

Šveice - vācu - Swissmedic (Swiss Agency for Therapeutic Products)

viiv healthcare gmbh - fostemsavirum - retardtabletten - fostemsavirum 600 mg ut fostemsavirum trometamolum, hydroxypropylcellulosum, hypromellosum, silica colloidalis anhydrica, magnesii stearas, poly(alcohol vinylicus) e 171 macrogolum 3350 talcum e 172 (flavum) e 172 (rubrum), pro compresso obducto. - hiv-infektion - synthetika

Eiropas Savienība - vācu - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovirus-infektionen - antivirale mittel zur systemischen anwendung - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). es sollte erwogen werden, um die offiziellen richtlinien über die geeignete anwendung von virostatika.

Šveice - vācu - Swissmedic (Swiss Agency for Therapeutic Products)

gilead sciences switzerland sàrl - lenacapavirum - injektionslösung - lenacapavirum 463.5 mg ut lenacapavirum natricum, macrogolum 300, aqua ad iniectabile, ad solutionem pro 1.5 ml corresp. natrium 10.99 mg. - hiv-infektion - synthetika

Šveice - vācu - Swissmedic (Swiss Agency for Therapeutic Products)

gilead sciences switzerland sàrl - lenacapavirum - filmtabletten - lenacapavirum 300 mg ut lenacapavirum natricum, copovidonum, poloxamerum 407, mannitolum, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 172 (flavum), e 172 (nigrum), e 172 (rubrum), pro compresso obducto corresp. natrium max. 17.93 mg. - hiv-infektion - synthetika

Šveice - vācu - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - maribavirum - filmtabletten - maribavirum 200 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, Überzug: poly(alcohol vinylicus) macrogolum 3350 e 171 talcum e 133 pro compresso obducto corresp. natrium max. 0.105 mg. - cmv infektion - synthetika

Eiropas Savienība - vācu - EMA (European Medicines Agency)

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv-infektionen - antivirale mittel zur systemischen anwendung - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

Eiropas Savienība - vācu - EMA (European Medicines Agency)

viiv healthcare b.v. - fostemsavir trometamol - hiv-infektionen - antivirale mittel zur systemischen anwendung - rukobia, in combination with other antiretrovirals, is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.

Eiropas Savienība - vācu - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - hiv-infektionen - antivirale mittel zur systemischen anwendung - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 und 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 und 5.

Šveice - vācu - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - raltegravirum - filmtabletten - raltegravirum 400 mg ut raltegravirum kalicum, cellulosum microcristallinum, lactosum monohydricum 26.1 mg, dikalii phosphas anhydricus, hypromellosum, poloxamerum 407, natrii stearylis fumaras, magnesii stearas, e 321, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 510 µg. - hiv-infektionen - synthetika